Literature DB >> 15526543

The risk factors of fibrosis in nonalcoholic steatohepatitis.

Carmen Fierbinţeanu-Braticevici1, Andreea Bengus, Monica Neamţu, R Usvat.   

Abstract

UNLABELLED: Nonalcoholic steatohepatitis (NASH) can be a severe progressive liver disease leading to the development of cirrhosis. The aim of this study was to assess the risk factors of fibrosis in NASH.
METHODS: The clinical, biochemical and histological features of 80 patients with NASH admitted at University Hospital from 1998 to 2000, were analyzed. The patients had no alcoholic, viral, autoimmune, drug induced or genetic liver disease. The fibrosis and necroinflammatory activity was associated with clinico-biochemical parameters and with oxidative stress. The clinical and biochemical parameters consist of: age, sex, body mass index (BMI), serum glucose, tryglycerides, alanine aminotransferase (ALT) and serum iron study (transferring saturation and ferritin). Liver iron overload was assessed by Pearls'staining and graded in four classes. The oxidative stress was evaluated by the levels of serum malon-dyaldehide (MDA) and serum total gluthatione (GSI4).
RESULTS: Septal fibrosis was present in 30 patients (27%) including cirrhosis in 4 patients (5%). Age > 45 years, B.M.I. >30 Kg/m2, serum tryglycerides >180 mg/dl, hyperglycemia > 220 mg/dl, serum ALT > 3N, increased hepatic iron and transferrin saturation percentage were independently associated with sepal fibrosis. Linear regression analysis showed that increased hepatic iron had the greatest association with the increase of lipid peroxidation (MDA > 250 nanomol/dl) and the decrease of serum gluthatione (< 40 micromol/dl).
CONCLUSIONS: The clinical and biochemical parameters which consist of age, BMI, serum ALT, glucose and tryglycerides, Perls' grade and the serum index of oxidative stress (MDA and GSH) are independent risk factors for fibrosis in NASH raising therapeutic implications for the management of these patients.

Entities:  

Mesh:

Year:  2002        PMID: 15526543

Source DB:  PubMed          Journal:  Rom J Intern Med        ISSN: 1220-4749


  8 in total

Review 1.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

2.  Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent.

Authors:  Diptadip Dattaroy; Ratanesh Kumar Seth; Sutapa Sarkar; Diana Kimono; Muayad Albadrani; Varun Chandrashekaran; Firas Al Hasson; Udai P Singh; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Eur J Pharmacol       Date:  2018-09-05       Impact factor: 4.432

Review 3.  Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

4.  Iron deposition and fat accumulation in dimethylnitrosamine-induced liver fibrosis in rat.

Authors:  Jin-Yang He; Wen-Hua Ge; Yuan Chen
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

Review 5.  Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.

Authors:  I N Guha; J Parkes; P R Roderick; S Harris; W M Rosenberg
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

6.  Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis.

Authors:  Mehmet Horoz; Cengiz Bolukbas; Fusun F Bolukbas; Tevfik Sabuncu; Mehmet Aslan; Serpil Sarifakiogullari; Necla Gunaydin; Ozcan Erel
Journal:  BMC Gastroenterol       Date:  2005-11-11       Impact factor: 3.067

7.  Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease.

Authors:  Özgür Pirgon; Hüseyin Bilgin; Ferhat Çekmez; Hüseyin Kurku; Bumin Nuri Dündar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

8.  Antioxidant therapy in nonalcoholic steatohepatitis.

Authors:  Said A Al-Busafi; Mamatha Bhat; Philip Wong; Peter Ghali; Marc Deschenes
Journal:  Hepat Res Treat       Date:  2012-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.